We are live on ! Find out more
GCM

Ghisallo Capital Management Portfolio holdings

AUM $3.63B
1-Year Est. Return 30.51%
This Fund
S&P 500
This Quarter Est. Return
+5.34%
1 Year Est. Return
+30.51%
3 Year Est. Return
+102.79%
5 Year Est. Return
+106.47%
10 Year Est. Return
–
AUM
$838M
AUM Growth
+$422M
Cap. Flow
+$414M
Cap. Flow %
49.47%
Top 10 Hldgs %
41.74%
Holding
134
New
65
Increased
4
Reduced
8
Closed
15

Top Buys

Rank Stock Value
1
KVUE icon
Kenvue
KVUE
+$57.3M
2
GEHC icon
GE HealthCare
GEHC
+$39.9M
3
PCG icon
PG&E
PCG
+$33.9M
4
RNR icon
RenaissanceRe
RNR
+$29.8M
5
AGL icon
Agilon Health
AGL
+$22.5M

Top Sells

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$26.6M
2
SCHW
Charles Schwab
SCHW
+$15.7M
3
CVII
Churchill Capital Corp VII Class A Common Stock
CVII
+$9.84M
4
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$9.36M
5
TEVA icon
Teva Pharmaceuticals
TEVA
+$7.96M

Sector Composition

Rank Sector Weight
1 Healthcare 19.54%
2 Technology 15.57%
3 Consumer Discretionary 14.85%
4 Industrials 10.26%
5 Financials 9.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RVMD icon
101
Revolution Medicines
RVMD
$44B
$669K 0.08%
25,000
– –
CHRS icon
102
Coherus Oncology
CHRS
$196M
$641K 0.08%
+150,000
New +$885K
TMCI icon
103
Treace Medical Concepts
TMCI
$309M
$640K 0.08%
25,000
– –
DH icon
104
Definitive Healthcare
DH
$75.3M
$550K 0.07%
50,000
– –
BITO icon
105
ProShares Bitcoin Strategy ETF
BITO
$1.47B
$518K 0.06%
+30,500
New +$494K
ENLT icon
106
Enlight Renewable Energy
ENLT
$11.9B
$501K 0.06%
28,223
-111,777
-80% -$1.98M
KURA icon
107
Kura Oncology
KURA
$850M
$476K 0.06%
+45,000
New +$532K
FDMT icon
108
4D Molecular Therapeutics
FDMT
$562M
$452K 0.05%
+25,000
New +$460K
BMEA icon
109
Biomea Fusion
BMEA
$91.3M
$439K 0.05%
20,000
– –
BWC
110
DELISTED
Blue Whale Acquisition Corp I Class A Ordinary Shares
BWC
$432K 0.05%
42,534
-129,362
-75% -$1.29M
LAW icon
111
CS Disco
LAW
$279M
$411K 0.05%
50,000
– –
PACB icon
112
Pacific Biosciences
PACB
$370M
$333K 0.04%
25,000
– –
BLUE
113
DELISTED
bluebird bio
BLUE
$329K 0.04%
5,000
– –
FNA
114
DELISTED
Paragon 28, Inc.
FNA
$266K 0.03%
15,000
– –
EPRT icon
115
Essential Properties Realty Trust
EPRT
$6.62B
$235K 0.03%
10,000
– –
MLYS icon
116
Mineralys Therapeutics
MLYS
$2.41B
$171K 0.02%
10,000
– –
GERN icon
117
Geron
GERN
$949M
$161K 0.02%
50,000
– –
PL icon
118
Planet Labs
PL
$8.53B
$129K 0.02%
40,000
– –
SVIIR
119
DELISTED
Spring Valley Acquisition Corp II Rights
SVIIR
$41.4K ﹤0.01%
211,791
-7,007
-3% -$1.12K
HII icon
120
Huntington Ingalls Industries
HII
$12.8B
– –
-23,900
Closed -$4.95M
LW icon
121
Lamb Weston
LW
$7.19B
– –
-48,500
Closed -$5.07M
SCHW
122
Charles Schwab
SCHW
$187B
– –
-300,000
Closed -$15.7M
SHLS icon
123
Shoals Technologies Group
SHLS
$1.5B
– –
-340,000
Closed -$7.75M
STGW icon
124
Stagwell
STGW
$2.24B
– –
-440,000
Closed -$3.26M
TEVA icon
125
Teva Pharmaceuticals
TEVA
$41.2B
– –
-900,000
Closed -$7.96M
2 3 4
5
6

Similar funds

VI
Vestcor Inc Fredericton, New Brunswick, Canada $3.63B AUM 21.49% 1-Year Est. Return
ACM
Advent Capital Management New York $3.63B AUM 0.29% 1-Year Est. Return
SCM
Saba Capital Management New York $3.62B AUM 12.96% 1-Year Est. Return
OCM
One Capital Management Westlake Village, California $3.65B AUM 15.32% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
AA
Advisory Alpha Holland, Michigan $3.66B AUM 14.99% 1-Year Est. Return
GCM
Gates Capital Management New York $3.66B AUM 12.63% 1-Year Est. Return
MTIM
Marathon Trading Investment Management Radnor, Pennsylvania $3.67B AUM 21.97% 1-Year Est. Return

Ghisallo Capital Management's Q2 2023 Portfolio in Review

As of Q2 2023, Ghisallo Capital Management held 134 positions worth $838M, up 101% from $416M the previous quarter. Its ten largest holdings account for 42% of the portfolio.

Ghisallo Capital Management deployed $414M of net new capital in Q2 2023, opening 65 new positions and adding to 4 existing holdings. Its largest new stake was Kenvue: 2,200,000 shares worth $58.1M.

By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 17% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Johnson & Johnson, an estimated $26.6M trimmed.

  • Ghisallo Capital Management's largest Q2 2023 buy was Kenvue: 2,200,000 shares worth $58.1M.
  • Ghisallo Capital Management added most to Nextpower Inc in Q2 2023, an estimated $15.7M increase.
  • Ghisallo Capital Management's biggest Q2 2023 reduction was Johnson & Johnson, cutting an estimated $26.6M.
  • Ghisallo Capital Management fully exited Charles Schwab in Q2 2023, selling an estimated $15.7M.
  • Ghisallo Capital Management's ten largest holdings make up 42% of its $838M portfolio in Q2 2023.
  • Ghisallo Capital Management opened 65 new positions and closed 15 in Q2 2023.
  • Ghisallo Capital Management's portfolio value rose 101% quarter-over-quarter to $838M.

Based on Ghisallo Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.